You are here

  • Home
  • Archive
  • Volume 10, Issue 4
  • [18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial

Article metrics

Article menu

Download PDFPDF

XML
Oncology
Protocol
[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial

 

Online download statistics by month:

Online download statistics by month: May 2020 to April 2024

AbstractFullPdf
May 202012110979
Jun 2020736644
Jul 2020605523
Aug 2020594728
Sep 2020747137
Oct 2020383529
Nov 2020413716
Dec 2020595424
Jan 2021453929
Feb 2021313012
Mar 2021474816
Apr 2021393816
May 2021161613
Jun 2021343218
Jul 2021232412
Aug 2021222218
Sep 2021171422
Oct 2021241931
Nov 2021262025
Dec 202134356
Jan 202212102
Feb 202215148
Mar 202225264
Apr 2022121410
May 2022141212
Jun 202218178
Jul 2022212110
Aug 202228288
Sep 2022111111
Oct 202218179
Nov 2022151311
Dec 202215162
Jan 202324238
Feb 202328246
Mar 2023252413
Apr 20238123
May 202311139
Jun 202324236
Jul 2023121111
Aug 202316153
Sep 202318173
Oct 202328286
Nov 202317172
Dec 202321187
Jan 202422217
Feb 202412124
Mar 2024999
Apr 20249106
Total13711287696